Advertisement
Letter to the Editor| Volume 398, P117-118, March 15, 2019

A rapidly progressive motor neuron disease associated to a natural killer cells leukaemia

Published:January 16, 2019DOI:https://doi.org/10.1016/j.jns.2019.01.029
      Current hypotheses suggest that neuroinflammation and the immune system play a complex role, either protective or toxic, in ALS pathogenesis [
      • Hooten K.G.
      • Beers D.R.
      • Zhao W.
      • Appel S.H.
      Protective and toxic neuroinflammation in amyotrophic lateral sclerosis.
      ,
      • Rentzos M.
      • Evangelopoulos E.
      • Sereti E.
      • et al.
      Alteration of T cell subsets in ALS: a systemic immune activation?.
      ,
      • Murdock B.J.
      • Zhou T.
      • Kashlan S.R.
      • et al.
      Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression.
      ]. In particular, compelling evidence indicate that increased blood level of natural killer (NK) and NK-T cells may contribute to the disease development and progression [
      • Rentzos M.
      • Evangelopoulos E.
      • Sereti E.
      • et al.
      Alteration of T cell subsets in ALS: a systemic immune activation?.
      ,
      • Murdock B.J.
      • Zhou T.
      • Kashlan S.R.
      • et al.
      Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hooten K.G.
        • Beers D.R.
        • Zhao W.
        • Appel S.H.
        Protective and toxic neuroinflammation in amyotrophic lateral sclerosis.
        Neurotherapeutics. 2015; 12: 364-375
        • Rentzos M.
        • Evangelopoulos E.
        • Sereti E.
        • et al.
        Alteration of T cell subsets in ALS: a systemic immune activation?.
        Acta Neurol. Scand. 2012; 125: 260-264
        • Murdock B.J.
        • Zhou T.
        • Kashlan S.R.
        • et al.
        Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression.
        JAMA Neurol. 2017; 74: 1446-1454
        • Kimura F.
        • Fujimura C.
        • Ishida S.
        • et al.
        Progression rate of ALSFRS-R at the time of diagnosis predicts survival time in ALS.
        Neurology. 2006; 66: 265-267
        • Younger D.S.
        • Rowland L.P.
        • Latov N.
        • et al.
        Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis.
        Ann. Neurol. 1991; 29: 78-86
        • Forsyth P.A.
        • Dalmau J.
        • Graus F.
        • et al.
        Motor neuron syndromes in cancer patients.
        Ann. Neurol. 1997; 41: 722-730
        • Spataro R.
        • La Bella V.
        Paraneoplastic motor neuron disease associated with breast cancer.
        Eur. J. Neurol. 2014; 21: e5-e6
        • Finkelstein A.
        • Kunis G.
        • Seksenyan A.
        • et al.
        Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS.
        PLoS ONE. 2011; 6e22374